TGen, Dell Spearhead Cancer Research

Dell will lend its computing muscle to TGen for a clinical trial that seeks to deliver treatments to children with a rare form of cancer.


Phoenix-based Translational Genomics Research Institute will evaluate the DNA of children with neuroblastoma, an often-fatal cancer that afflicts one in 100,000 children.


TGen will work with doctors treating children afflicted with the disease with the goal of developing tailored medical treatments.



About admin

More in: Noteworthy

From Frontdoors Magazine

Back to Top